Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
391 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5913359

The global growth factors market is poised for substantial expansion, with a remarkable surge in revenue from US $2.2 billion in 2024 to an estimated US $3.8 billion by the end of 2031. Manufacturers are playing a pivotal role in propelling this growth, revolutionizing skin regeneration, wound healing, and therapeutic applications.

Manufacturers Spearhead Market Growth

Growth factors have emerged as a cornerstone for skin regeneration and wound healing. Researchers are diligently working on pioneering products that extend beyond single growth factor solutions, paving the way for significant opportunities in the market. Additionally, the rapid growth of the Asia Pacific region and a limited number of companies specializing in Good Manufacturing Practice (GMP)-grade products create vast prospects for growth factor manufacturers.

Cytokine and Growth Factors Therapy Expands

The therapeutic potential of cytokine and growth factors in treating a range of disorders is expected to bolster market expansion. The rising prevalence of autoimmune diseases and cancer further fuels this growth trajectory.

Key Players Drive Expansion

Leading industry players are strategically focusing on new product approvals, launches, collaborations, agreements, and partnerships. These tactics are aimed at strengthening product portfolios and expanding regional presence. Mergers and acquisitions, along with investments in research and development, are also key strategies to harness growth factors in various therapeutic and scientific domains.

Challenges Ahead

However, the growth factors market faces its share of challenges, primarily stemming from high costs and a shortage of skilled professionals. The cost of certain growth factors hampers their adoption in research laboratories. A dearth of qualified experts and limited access to necessary equipment and accessories further impede market expansion.

Country-wise Insights

Why the U.S. is Thriving

The United States is witnessing a burgeoning demand for growth factors, driven by government initiatives supporting research activities and the growing importance of growth factors and cytokines in stem cell biology.

China's Emergence

China has become a prominent market for growth factors, particularly in the wake of the COVID-19 pandemic. As larger Chinese companies focus on developing growth factor-based medicines to combat the virus, the market for these products is rapidly expanding throughout China and East Asia.

Germany's Appeal

Germany stands out as a lucrative market for growth factors in Europe due to rising healthcare spending and the presence of robust manufacturing facilities. Major companies are expanding their product offerings through strategic acquisitions, such as Sartorius AG's acquisition of CellGenix in 2021 to bolster its cell and gene therapy product line.

Competitive Landscape

Key players in the growth factors market, including Thermo Fisher Scientific, Lonza Group AG, Merck KGaA, and others, are actively pursuing strategies to enhance their global presence. These strategies encompass new product releases, business expansion, approvals, partnerships, agreements, collaborations, and diversified distribution channels, including online sales.

Key Companies Profiled

Thermo Fisher Scientific
Lonza Group AG
Merck KGaA
General Electronics Company
F. Hoffmann-La Roche Ltd
Applied Biological Materials (abm), Inc
Abcam plc.
Cell Signaling Technology, Inc.
Meridian Bioscience Inc.
Sartorius CellGenix GmbH
Bio-Techne.
Proteintech Group, Inc.
Miltenyi Biotec
Creative Bioarray
Akron Biotech
Sino Biological Inc.
Repligen Corporation
LEADGENE BIOMEDICAL, INC.
PeproTech Inc.

Key Segments of the Growth Factors Industry Research

By Product:

Transforming Growth Factors (TGF)
Activin
Bone Morphogenetic Proteins (BMPs)
TGF-beta Proteins
Epidermal Growth Factors (EGFs)
Platelet-Derived Growth Factors (PDGFs)
Fibroblast Growth Factors (FGFs)
Insulin-like Growth Factors (IGFs)
Vascular Endothelial Growth Factors (VEGFs)
Hepatocyte Growth Factors (HGFs)
Tumour Necrosis Factors (TNFs)
Interleukins
Others

By Grade:

GMP Grade
NON-GMP Grade

By Application:

Oncology Research
Hematology Research
Wound Healing Research
Dermatology Research
Cardiovascular Disease & Diabetes
Cell therapy and Ex vivo manufacturing
Others

By End User:

Pharmaceutical and Biotechnology Companies
Research Centres & Academic Institutes
CMO and CDMO

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Growth Factors Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Growth Factors Market Outlook, 2018 - 2031

3.1. Global Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Transforming Growth Factors (TGF)
3.1.1.1.1. Activin
3.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
3.1.1.1.3. TGF-beta Proteins
3.1.1.2. Epidermal Growth Factors (EGFs)
3.1.1.3. Platelet-Derived Growth Factors (PDGFs)
3.1.1.4. Fibroblast Growth Factors (FGFs)
3.1.1.5. Insulin-like Growth Factors (IGFs)
3.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
3.1.1.7. Hepatocyte Growth Factors (HGFs)
3.1.1.8. Tumour Necrosis Factors (TNFs)
3.1.1.9. Interleukins
3.1.1.10. Others
3.2. Global Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. GMP Grade
3.2.1.2. NON-GMP Grade
3.3. Global Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Oncology Research
3.3.1.2. Hematology Research
3.3.1.3. Wound Healing Research
3.3.1.4. Dermatology Research
3.3.1.5. Cardiovascular Disease & Diabetes
3.3.1.6. Cell therapy and Ex vivo manufacturing
3.3.1.7. Others
3.4. Global Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Pharmaceutical and Biotechnology Companies
3.4.1.2. Research Centres & Academic Institutes
3.4.1.3. CMO and CDMO
3.5. Global Growth Factors Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa

4. North America Growth Factors Market Outlook, 2018 - 2031

4.1. North America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Transforming Growth Factors (TGF)
4.1.1.1.1. Activin
4.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
4.1.1.1.3. TGF-beta Proteins
4.1.1.2. Epidermal Growth Factors (EGFs)
4.1.1.3. Platelet-Derived Growth Factors (PDGFs)
4.1.1.4. Fibroblast Growth Factors (FGFs)
4.1.1.5. Insulin-like Growth Factors (IGFs)
4.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
4.1.1.7. Hepatocyte Growth Factors (HGFs)
4.1.1.8. Tumour Necrosis Factors (TNFs)
4.1.1.9. Interleukins
4.1.1.10. Others
4.2. North America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. GMP Grade
4.2.1.2. NON-GMP Grade
4.3. North America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Oncology Research
4.3.1.2. Hematology Research
4.3.1.3. Wound Healing Research
4.3.1.4. Dermatology Research
4.3.1.5. Cardiovascular Disease & Diabetes
4.3.1.6. Cell therapy and Ex vivo manufacturing
4.3.1.7. Others
4.4. North America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Pharmaceutical and Biotechnology Companies
4.4.1.2. Research Centres & Academic Institutes
4.4.1.3. CMO and CDMO
4.5. North America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.2. U.S. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.3. U.S. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.4. U.S. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.5. Canada Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.6. Canada Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.7. Canada Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.1.8. Canada Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Growth Factors Market Outlook, 2018 - 2031

5.1. Europe Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Transforming Growth Factors (TGF)
5.1.1.1.1. Activin
5.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
5.1.1.1.3. TGF-beta Proteins
5.1.1.2. Epidermal Growth Factors (EGFs)
5.1.1.3. Platelet-Derived Growth Factors (PDGFs)
5.1.1.4. Fibroblast Growth Factors (FGFs)
5.1.1.5. Insulin-like Growth Factors (IGFs)
5.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
5.1.1.7. Hepatocyte Growth Factors (HGFs)
5.1.1.8. Tumour Necrosis Factors (TNFs)
5.1.1.9. Interleukins
5.1.1.10. Others
5.2. Europe Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. GMP Grade
5.2.1.2. NON-GMP Grade
5.3. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Oncology Research
5.3.1.2. Hematology Research
5.3.1.3. Wound Healing Research
5.3.1.4. Dermatology Research
5.3.1.5. Cardiovascular Disease & Diabetes
5.3.1.6. Cell therapy and Ex vivo manufacturing
5.3.1.7. Others
5.4. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Pharmaceutical and Biotechnology Companies
5.4.1.2. Research Centres & Academic Institutes
5.4.1.3. CMO and CDMO
5.5. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.2. Germany Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.3. Germany Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.4. Germany Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.5. U.K. Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.6. U.K. Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.7. U.K. Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.8. U.K. Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.9. France Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.10. France Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.11. France Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.12. France Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.13. Italy Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.14. Italy Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.15. Italy Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.16. Italy Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.17. Turkey Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.18. Turkey Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.19. Turkey Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.20. Turkey Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.21. Russia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.22. Russia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.23. Russia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.24. Russia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.25. Rest of Europe Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.26. Rest of Europe Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.27. Rest of Europe Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1.28. Rest of Europe Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Growth Factors Market Outlook, 2018 - 2031

6.1. Asia Pacific Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Transforming Growth Factors (TGF)
6.1.1.1.1. Activin
6.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
6.1.1.1.3. TGF-beta Proteins
6.1.1.2. Epidermal Growth Factors (EGFs)
6.1.1.3. Platelet-Derived Growth Factors (PDGFs)
6.1.1.4. Fibroblast Growth Factors (FGFs)
6.1.1.5. Insulin-like Growth Factors (IGFs)
6.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
6.1.1.7. Hepatocyte Growth Factors (HGFs)
6.1.1.8. Tumour Necrosis Factors (TNFs)
6.1.1.9. Interleukins
6.1.1.10. Others
6.2. Asia Pacific Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. GMP Grade
6.2.1.2. NON-GMP Grade
6.3. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Oncology Research
6.3.1.2. Hematology Research
6.3.1.3. Wound Healing Research
6.3.1.4. Dermatology Research
6.3.1.5. Cardiovascular Disease & Diabetes
6.3.1.6. Cell therapy and Ex vivo manufacturing
6.3.1.7. Others
6.4. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Pharmaceutical and Biotechnology Companies
6.4.1.2. Research Centres & Academic Institutes
6.4.1.3. CMO and CDMO
6.5. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.2. China Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.3. China Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.4. China Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.5. Japan Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.6. Japan Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.7. Japan Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.8. Japan Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.9. South Korea Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.10. South Korea Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.11. South Korea Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.12. South Korea Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.13. India Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.14. India Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.15. India Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.16. India Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.17. Southeast Asia Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.18. Southeast Asia Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.19. Southeast Asia Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.20. Southeast Asia Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Growth Factors Market Outlook, 2018 - 2031

7.1. Latin America Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Transforming Growth Factors (TGF)
7.1.1.1.1. Activin
7.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
7.1.1.1.3. TGF-beta Proteins
7.1.1.2. Epidermal Growth Factors (EGFs)
7.1.1.3. Platelet-Derived Growth Factors (PDGFs)
7.1.1.4. Fibroblast Growth Factors (FGFs)
7.1.1.5. Insulin-like Growth Factors (IGFs)
7.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
7.1.1.7. Hepatocyte Growth Factors (HGFs)
7.1.1.8. Tumour Necrosis Factors (TNFs)
7.1.1.9. Interleukins
7.1.1.10. Others
7.2. Latin America Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1.1. GMP Grade
7.2.1.2. NON-GMP Grade
7.3. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Oncology Research
7.3.1.2. Hematology Research
7.3.1.3. Wound Healing Research
7.3.1.4. Dermatology Research
7.3.1.5. Cardiovascular Disease & Diabetes
7.3.1.6. Cell therapy and Ex vivo manufacturing
7.3.1.7. Others
7.4. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Pharmaceutical and Biotechnology Companies
7.4.1.2. Research Centres & Academic Institutes
7.4.1.3. CMO and CDMO
7.5. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.2. Brazil Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.3. Brazil Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.4. Brazil Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.5. Mexico Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.6. Mexico Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.7. Mexico Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.8. Mexico Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.9. Argentina Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.10. Argentina Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.11. Argentina Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.12. Argentina Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.13. Rest of Latin America Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.14. Rest of Latin America Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.15. Rest of Latin America Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.16. Rest of Latin America Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Growth Factors Market Outlook, 2018 - 2031

8.1. Middle East & Africa Growth Factors Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Transforming Growth Factors (TGF)
8.1.1.1.1. Activin
8.1.1.1.2. Bone Morphogenetic Proteins (BMPs)
8.1.1.1.3. TGF-beta Proteins
8.1.1.2. Epidermal Growth Factors (EGFs)
8.1.1.3. Platelet-Derived Growth Factors (PDGFs)
8.1.1.4. Fibroblast Growth Factors (FGFs)
8.1.1.5. Insulin-like Growth Factors (IGFs)
8.1.1.6. Vascular Endothelial Growth Factors (VEGFs)
8.1.1.7. Hepatocyte Growth Factors (HGFs)
8.1.1.8. Tumour Necrosis Factors (TNFs)
8.1.1.9. Interleukins
8.1.1.10. Others
8.2. Middle East & Africa Growth Factors Market Outlook, by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. GMP Grade
8.2.1.2. NON-GMP Grade
8.3. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Oncology Research
8.3.1.2. Hematology Research
8.3.1.3. Wound Healing Research
8.3.1.4. Dermatology Research
8.3.1.5. Cardiovascular Disease & Diabetes
8.3.1.6. Cell therapy and Ex vivo manufacturing
8.3.1.7. Others
8.4. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Pharmaceutical and Biotechnology Companies
8.4.1.2. Research Centres & Academic Institutes
8.4.1.3. CMO and CDMO
8.5. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.2. GCC Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.3. GCC Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.4. GCC Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.5. South Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.6. South Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.7. South Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.8. South Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.9. Egypt Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.10. Egypt Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.11. Egypt Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.12. Egypt Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.13. Nigeria Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.14. Nigeria Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.15. Nigeria Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.16. Nigeria Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Growth Factors Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Growth Factors Market by Grade, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Growth Factors Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Growth Factors Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Application vs by Grade Heatmap
9.2. Manufacturer vs by Grade Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Thermo Fisher Scientific Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Lonza Group AG
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Merck KGaA
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. General Electronics Company
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. F. Hoffmann-La Roche Ltd
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Applied Biological Materials (abm), Inc
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Abcam plc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Cell Signaling Technology, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.8.5. Meridian Bioscience Inc.
9.5.8.6. Company Overview
9.5.8.7. Product Portfolio
9.5.8.8. Financial Overview
9.5.8.9. Business Strategies and Development
9.5.9. Sartorius CellGenix GmbH
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Bio-Techne
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Proteintech Group, Inc
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Miltenyi Biotec
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Creative Bioarray
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Akron Biotech
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Sino Biological Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. Repligen corporation
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. Business Strategies and Development
9.5.17. LEADGENE BIOMEDICAL, INC.
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
9.5.18. PeproTech In
9.5.18.1. Company Overview
9.5.18.2. Product Portfolio
9.5.18.3. Financial Overview
9.5.18.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

Thermo Fisher Scientific Inc.
Lonza Group AG
Merck KGaA
General Electronics Company
F. Hoffmann-La Roche Ltd
Applied Biological Materials (abm), Inc
Abcam plc.
Cell Signaling Technology, Inc.
Meridian Bioscience Inc.
Sartorius CellGenix GmbH
Bio-Techne.
Proteintech Group, Inc.
Miltenyi Biotec
Creative Bioarray
Akron Biotech
Sino Biological Inc.
Repligen corporation
LEADGENE BIOMEDICAL, INC.
PeproTech Inc.

Methodology

LOADING...